Real-Time Quote
 -0.31 / -3.37%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Verastem, Inc. is a clinical biopharmaceutical company, which is focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. The company is developing small molecule inhibitors of signaling pathways which includes Focal Adhesion Kinase (FAK), PI3K/mTOR and Wnt that are critical to cancer stem cell survival and proliferation. Verastem was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg and Christoph H. Westphal on August 4, 2010 and is headquartered in Cambridge, MA.

Contact Information

Verastem, Inc.
215 First Street
Cambridge Massachusetts 02142-1213
P:(617) 252-9300
Investor Relations:
(617) 252-9314



Individual stakeholders36.62%
Mutual fund holders29.36%
Other institutional23.86%

Top Executives

Robert M. ForresterPresident, Chief Executive Officer & Director
John B. GreenChief Financial Officer
Jonathan PachterVice President & Head-Research
Joanna C. HorobinChief Medical Officer
Daniel W. PatersonChief Business Officer, VP & Head-Diagnostics

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.